Octanate (Human Coagulation Factor Viii)

Human Coagulation Factor VIII, the active ingredient in Octanate, is a blood clotting factor presented as a sterile solution for intravenous use. It replaces deficient factor VIII in patients with hemophilia A, helping to control and prevent bleeding episodes. GNH USA supplies Octanate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

GNH USA supplies Octanate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Octanate is a recombinant factor VIII product that acts on the intrinsic pathway of the coagulation cascade in hemophilia A patients. - Hemophilia A (severe): Provides factor VIII replacement to achieve hemostasis and reduce bleeding frequency. - Hemophilia A (moderate): Supports routine prophylaxis to maintain adequate factor levels. - Hemophilia A (mild) :          ...   ...  ...  ... ... ....  ... ...  ...  ... ...  ...  ... ...  -     …  …   …  ....  …  … … … … … … ...